Food and Drug Administration Commissioner Scott Gottlieb, M.D., says addressing the opioid crisis will involve the concerted efforts of many stakeholders – public and private, local and federal. “With millions of Americans misusing prescription opioids and more than 40 people dying every day from opioid overdoses, it’s become abundantly clear that we need to do everything we can to get ahead of this crisis.”
Gottlieb spoke at the workshop “Strategies for Promoting the Safe Use and Appropriate Prescribing of Prescription Opioids” hosted by the Duke-Robert J. Margolis Center for Health Policy on February 15 in Washington D.C.
With many stakeholders invested in stemming the tide of increasing opioid misuse and mitigating risks for opioid therapy patients, Mark McClellan, M.D., director, Duke-Robert J. Margolis Center for Health Policy and Research!America board member said that “assessing the impact of strategies on patient health outcomes and public health is critical for effective implementation.”
John Halpin, M.D., Medical Officer for the Opioid Overdoes Epidemiology and Surveillance Team, Centers for Disease Control and Prevention (CDC), said utilizing the CDC prescribing guidelines for chronic pain hinges on developing accessible communication materials, educating providers, and working with the healthcare system for guideline integration.
For a video of the workshop, click here.